Daclizumab and Alemtuzumab as Induction Agents in Adult Intestinal and Multivisceral Transplantation: Rejection and Infection Rates in 40 Recipients During the Early Postoperative Period
Title:
Daclizumab and Alemtuzumab as Induction Agents in Adult Intestinal and Multivisceral Transplantation: Rejection and Infection Rates in 40 Recipients During the Early Postoperative Period
Author:
Zanfi, C. Lauro, A. Cescon, M. Dazzi, A. Ercolani, G. Grazi, G.L. Zanello, M. Vivarelli, M. Del Gaudio, M. Ravaioli, M. Cucchetti, A. Vetrone, G. Tuci, F. Di Gioia, P. Lazzarotto, T. D'Errico, A. Bagni, A. Faenza, S. Siniscalchi, A. Pironi, L. Pinna, A.D.